Pfizer Ltd is engaged in manufacturing, marketing, trading and export of pharmaceutical products. It manufactures products through its own facility and also has various independent contract/ third party manufacturers based across the country and sells its products through independent distributors primarily in India. It is the 3rd largest multinational pharmaceutical company in India.
Financial Results:
Pfizer Ltd reported Revenues for Q2FY24 of ₹575.00 Crores down from ₹637.00 Crore year on year, a fall of 9.73%.
Total Expenses for Q2FY24 of ₹411.00 Crores down from ₹435.00 Crores year on year, a fall of 5.52%.
Consolidated Net Profit of ₹149.00 Crores down 52.09% from ₹311.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹32.56, down 52.12% from ₹68.00 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.